Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

(2020) Sundy N.Y. Yang et al.   ANTIVIRAL RESEARCH

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

(2020) Hasan K. Siddiqi et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Racial demographics and COVID-19 confirmed cases and deaths: a correlational analysis of 2886 US counties

(2020) Uma V Mahajan et al.   JOURNAL OF PUBLIC HEALTH

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

(2020) Mike Bray et al.   ANTIVIRAL RESEARCH

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

(2020) Leon Caly et al.   ANTIVIRAL RESEARCH

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

(2020) Christoph D. Spinner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States

(2020) Pinar Karaca-Mandic et al.   JAMA Internal Medicine

COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution

(2020) Marcelo Beltrão Molento   One Health

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial

(2018) Menno R Smit et al.   LANCET INFECTIOUS DISEASES

Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

(2013) M.Y.F. Tay et al.   ANTIVIRAL RESEARCH

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

(2012) Kylie M. Wagstaff et al.   BIOCHEMICAL JOURNAL

Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug

(2012) E. Mastrangelo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ivermectin: 25 years and still going strong

(2007) S. Õmura   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS